Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-03

Clinical Trial Update: Study of the ReGelTec HYDRAFIL System [NA]

View source ↗

Summary

The clinical trial evaluating the ReGelTec HYDRAFIL System for degenerative disc disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ReGelTec HYDRAFIL System

Snippet

Sponsor: ReGelTec, Inc. | Conditions: Degenerative Disc Disease | NA | Status: COMPLETED